Disclosures for "MR Imaging Stabilization of Leukodystrophy-like MOG-associated Disease in a Patient Treated with Rituximab"
-
Dr. Gupta has nothing to disclose.
-
Dr. Sweeney has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Genentech. Dr. Sweeney has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis.